We also observed a high frequency of variants for NBPF12 and PLIN4. Interestingly, in silico analyses of BCa genomics data from TCGA and the International Cancer Genome Consortium have identified NBPF12 as a BCa-driver gene with an estimated 0.3% substitution rate [42]. This evidence concerns the gene NBPF12 and cancer.